Gottfried Von Keudell, Md Phd

This study is testing an immunotherapy drug called odronextamab in people with a specific type of slow-growing blood cancer (follicular lymphoma) who have not yet received any treatment and have a low amount of cancer. The goal is to see if this drug, which helps the body's own i…

This study is testing if a combination of two drugs, rituximab and venetoclax, can effectively treat marginal zone lymphoma (MZL) in people who haven't had chemotherapy before. The goal is to control the cancer and keep it from coming back. About 33 participants will receive the …

This study is testing an experimental drug called epcoritamab in patients with Waldenstrom Macroglobulinemia, a rare blood cancer, who have already tried other treatments. The drug is a type of antibody designed to help the patient's own immune system find and attack cancer cells…